Why Attend TCTAP & AP VALVES 2020 Virtual?
- Highlight Sessions
Upgrade your knowledge on diverse interventional cardiology topics through world-renowned experts lectures and interactive discussions. - Special Hot Debate
Join relentless debate on left main revascularization with interventional and surgical masters. - Special Sessions
Highlights on COVID-19 via brand-new lectures from cardiology and infectious disease specialists. - Masters' Taped Cases
Share and gain particular intervention techniques with master-class interventional experts. - Daily Newspaper
Stay informed with hot topics covered in a day by checking out daily newspaper articles issued right after the day. - Live Chat Service
Participate in a real-time chat platform to discuss any questions you have or wish to dive deeper into through the live chat feature. - e-Science Station
Discover latest idea on selected cases and abstracts, and leave your comment. - Satellite Symposium
Take a look at the intriguing lectures supported by the various sponsors. - Training Course
Gain particular intervention techniques by watching demonstration of industry professionals. - Virtual Booth
Browse virtual booths of sponsors and get related information.
Who Attend TCTAP & AP VALVES 2020 Virtual?
- Interventional cardiologists
- General cardiologists
- Physicians interested in cardiology and vascular medicine
- Radiologists
- Basic scientists
- Vascular medicine specialists
- Vascular surgeons
- Cardiac surgeons
- Interventional pediatricians
- Nurses and technologists
- Other health care professionals with special interest in the interventional vascular therapy and medicine
Who Supports TCTAP & AP VALVES 2020 Virtual?
TCTAP & AP VALVES 2020 Virtual is organized by CardioVasucular Research Foundation (CVRF) and supported by Heart Institute of Asan Medical Center (Seoul, Korea) and partially funded by educational grants from commercial supporters.
The CardioVascular Research Foundation wishes to extend special appreciation to Clinical Research Center for Ischemic Heart Disease for their continued support to our programs.